5PSQ-027 Misuse assessment and risks of NSAIDs prescriptions for elderly patients in surgical units

Background and importanceNon-steroidal anti-inflammatory drugs (NSAIDs) should be used with caution for elderly patients due to the high risk of gastrointestinal and renal adverse effects (AE). However, this drug class is widely used in the perioperative period for their analgesic properties, to spa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of hospital pharmacy. Science and practice 2022-03, Vol.29 (Suppl 1), p.A126-A126
Hauptverfasser: Lombardi, J, Almolki, M, Petit, C, Mondoloni, P, Grangeasse, L, Leroy, B, Renzullo, C, Razzouq, N, Penaud, JF, Coutet, J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A126
container_issue Suppl 1
container_start_page A126
container_title European journal of hospital pharmacy. Science and practice
container_volume 29
creator Lombardi, J
Almolki, M
Petit, C
Mondoloni, P
Grangeasse, L
Leroy, B
Renzullo, C
Razzouq, N
Penaud, JF
Coutet, J
description Background and importanceNon-steroidal anti-inflammatory drugs (NSAIDs) should be used with caution for elderly patients due to the high risk of gastrointestinal and renal adverse effects (AE). However, this drug class is widely used in the perioperative period for their analgesic properties, to spare using opioids. Due to serious AE imputed by pharmacovigilance in Orthopedic Surgery Departments (OSD), a study of NSAIDs prescriptions was conducted in this care unit. Clinical pharmacy development in OSD highlighted dysfunctions in prescribing NSAIDs for patients aged over 75 years who are at high risk of AE.Aim and objectivesTo quantify how commonly postoperative prescription of NSAIDs are used and to assess the risks associated for patients aged over 75 years in OSD.Material and methodsWe performed a retrospective, observational study between January and October 2021 on all NSAIDs prescriptions for patients aged over 75 years in OSD. Treatments which may cause renal failure in elderly patients (angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin receptor blockers (ARB), diuretics) were noted. Specific attention was given to patients having presented a serious AE including a declaration to pharmacovigilance.ResultsIn total, 584 patients received NSAIDs in the OSD. 80 patients were aged over 75 years (13.7%), of which 21 patients were taking ACE inhibitors (26%) at the same time, 17 patients an ARB (21%) and 13 patients diuretics (16%). A combination of three nephrotoxic drugs was found for 2 patients and a combination of two for 20 patients. The median creatinine before surgery was 69 µM (40–141 µM) and median renal clearance was 78 mL/min. Serious renal AE were identified in 5 patients (6.25%) leading to prolonged hospitalisation and haemodialysis for one patient. AE were present within 48 hours of taking NSAIDs. No other AE were detected.Conclusion and relevanceThe inappropriate prescriptions of NSAIDs observed in elderly patient and their association with other potentially nephrotoxic drugs increases the risk of renal AE. The actions implemented initially were setting analgesic protocols adapted to the patient’s age according to the latest recommendations. Secondly, both pharmaceutical and medical prescriptions were being monitored daily. Since surgery involves several prescribers (anaesthesiologists, surgeons, doctors), harmonising prescription practices is currently being considered.References and/or acknowledgementsConflict of inter
doi_str_mv 10.1136/ejhpharm-2022-eahp.264
format Article
fullrecord <record><control><sourceid>proquest_bmj_j</sourceid><recordid>TN_cdi_proquest_journals_2672360852</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2672360852</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1194-be853001f683aeb8696b720b7ecaeb7d34b5367f4d36f7518875ec7790e755683</originalsourceid><addsrcrecordid>eNpFkMtKw0AUhoMoWGpfQQZcp859kmWpt0K9UV2HmeTETk2TOCdZuHPji_okptTL6vwHvv8c-KLolNEpY0Kfw2bdrm3YxpxyHoNdt1Ou5UE04lSaOE21PPzLSh9HE0TvqBIiSaVIRxGoh9VjTLn5-vi89dgjEIsIiFuoO2LrggSPr0iaktytZosLJG0AzINvO9_USMomEKgKCNU7aW3nhxYSXxPsw4vPbUX62nd4Eh2VtkKY_Mxx9Hx1-TS_iZf314v5bBk7xlIZO0iUoJSVOhEWXKJT7QynzkA-rKYQ0imhTSkLoUujWJIYBbkxKQWj1FAaR2f7u21o3nrALts0faiHlxnXhgtNE8UHiu8pt938A4xmO6PZr9FsZzTbGR26UnwDwpltig</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2672360852</pqid></control><display><type>article</type><title>5PSQ-027 Misuse assessment and risks of NSAIDs prescriptions for elderly patients in surgical units</title><source>PubMed (Medline)</source><source>EZB Electronic Journals Library</source><creator>Lombardi, J ; Almolki, M ; Petit, C ; Mondoloni, P ; Grangeasse, L ; Leroy, B ; Renzullo, C ; Razzouq, N ; Penaud, JF ; Coutet, J</creator><creatorcontrib>Lombardi, J ; Almolki, M ; Petit, C ; Mondoloni, P ; Grangeasse, L ; Leroy, B ; Renzullo, C ; Razzouq, N ; Penaud, JF ; Coutet, J</creatorcontrib><description>Background and importanceNon-steroidal anti-inflammatory drugs (NSAIDs) should be used with caution for elderly patients due to the high risk of gastrointestinal and renal adverse effects (AE). However, this drug class is widely used in the perioperative period for their analgesic properties, to spare using opioids. Due to serious AE imputed by pharmacovigilance in Orthopedic Surgery Departments (OSD), a study of NSAIDs prescriptions was conducted in this care unit. Clinical pharmacy development in OSD highlighted dysfunctions in prescribing NSAIDs for patients aged over 75 years who are at high risk of AE.Aim and objectivesTo quantify how commonly postoperative prescription of NSAIDs are used and to assess the risks associated for patients aged over 75 years in OSD.Material and methodsWe performed a retrospective, observational study between January and October 2021 on all NSAIDs prescriptions for patients aged over 75 years in OSD. Treatments which may cause renal failure in elderly patients (angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin receptor blockers (ARB), diuretics) were noted. Specific attention was given to patients having presented a serious AE including a declaration to pharmacovigilance.ResultsIn total, 584 patients received NSAIDs in the OSD. 80 patients were aged over 75 years (13.7%), of which 21 patients were taking ACE inhibitors (26%) at the same time, 17 patients an ARB (21%) and 13 patients diuretics (16%). A combination of three nephrotoxic drugs was found for 2 patients and a combination of two for 20 patients. The median creatinine before surgery was 69 µM (40–141 µM) and median renal clearance was 78 mL/min. Serious renal AE were identified in 5 patients (6.25%) leading to prolonged hospitalisation and haemodialysis for one patient. AE were present within 48 hours of taking NSAIDs. No other AE were detected.Conclusion and relevanceThe inappropriate prescriptions of NSAIDs observed in elderly patient and their association with other potentially nephrotoxic drugs increases the risk of renal AE. The actions implemented initially were setting analgesic protocols adapted to the patient’s age according to the latest recommendations. Secondly, both pharmaceutical and medical prescriptions were being monitored daily. Since surgery involves several prescribers (anaesthesiologists, surgeons, doctors), harmonising prescription practices is currently being considered.References and/or acknowledgementsConflict of interestNo conflict of interest</description><identifier>ISSN: 2047-9956</identifier><identifier>EISSN: 2047-9964</identifier><identifier>DOI: 10.1136/ejhpharm-2022-eahp.264</identifier><language>eng</language><publisher>London: British Medical Journal Publishing Group</publisher><subject>Analgesics ; Bone surgery ; Conflicts of interest ; Diuretics ; Patients ; Pharmacovigilance ; Prescriptions ; Section 5: Patient safety and quality assurance</subject><ispartof>European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A126-A126</ispartof><rights>European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2022 European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids></links><search><creatorcontrib>Lombardi, J</creatorcontrib><creatorcontrib>Almolki, M</creatorcontrib><creatorcontrib>Petit, C</creatorcontrib><creatorcontrib>Mondoloni, P</creatorcontrib><creatorcontrib>Grangeasse, L</creatorcontrib><creatorcontrib>Leroy, B</creatorcontrib><creatorcontrib>Renzullo, C</creatorcontrib><creatorcontrib>Razzouq, N</creatorcontrib><creatorcontrib>Penaud, JF</creatorcontrib><creatorcontrib>Coutet, J</creatorcontrib><title>5PSQ-027 Misuse assessment and risks of NSAIDs prescriptions for elderly patients in surgical units</title><title>European journal of hospital pharmacy. Science and practice</title><addtitle>Eur J Hosp Pharm</addtitle><description>Background and importanceNon-steroidal anti-inflammatory drugs (NSAIDs) should be used with caution for elderly patients due to the high risk of gastrointestinal and renal adverse effects (AE). However, this drug class is widely used in the perioperative period for their analgesic properties, to spare using opioids. Due to serious AE imputed by pharmacovigilance in Orthopedic Surgery Departments (OSD), a study of NSAIDs prescriptions was conducted in this care unit. Clinical pharmacy development in OSD highlighted dysfunctions in prescribing NSAIDs for patients aged over 75 years who are at high risk of AE.Aim and objectivesTo quantify how commonly postoperative prescription of NSAIDs are used and to assess the risks associated for patients aged over 75 years in OSD.Material and methodsWe performed a retrospective, observational study between January and October 2021 on all NSAIDs prescriptions for patients aged over 75 years in OSD. Treatments which may cause renal failure in elderly patients (angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin receptor blockers (ARB), diuretics) were noted. Specific attention was given to patients having presented a serious AE including a declaration to pharmacovigilance.ResultsIn total, 584 patients received NSAIDs in the OSD. 80 patients were aged over 75 years (13.7%), of which 21 patients were taking ACE inhibitors (26%) at the same time, 17 patients an ARB (21%) and 13 patients diuretics (16%). A combination of three nephrotoxic drugs was found for 2 patients and a combination of two for 20 patients. The median creatinine before surgery was 69 µM (40–141 µM) and median renal clearance was 78 mL/min. Serious renal AE were identified in 5 patients (6.25%) leading to prolonged hospitalisation and haemodialysis for one patient. AE were present within 48 hours of taking NSAIDs. No other AE were detected.Conclusion and relevanceThe inappropriate prescriptions of NSAIDs observed in elderly patient and their association with other potentially nephrotoxic drugs increases the risk of renal AE. The actions implemented initially were setting analgesic protocols adapted to the patient’s age according to the latest recommendations. Secondly, both pharmaceutical and medical prescriptions were being monitored daily. Since surgery involves several prescribers (anaesthesiologists, surgeons, doctors), harmonising prescription practices is currently being considered.References and/or acknowledgementsConflict of interestNo conflict of interest</description><subject>Analgesics</subject><subject>Bone surgery</subject><subject>Conflicts of interest</subject><subject>Diuretics</subject><subject>Patients</subject><subject>Pharmacovigilance</subject><subject>Prescriptions</subject><subject>Section 5: Patient safety and quality assurance</subject><issn>2047-9956</issn><issn>2047-9964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpFkMtKw0AUhoMoWGpfQQZcp859kmWpt0K9UV2HmeTETk2TOCdZuHPji_okptTL6vwHvv8c-KLolNEpY0Kfw2bdrm3YxpxyHoNdt1Ou5UE04lSaOE21PPzLSh9HE0TvqBIiSaVIRxGoh9VjTLn5-vi89dgjEIsIiFuoO2LrggSPr0iaktytZosLJG0AzINvO9_USMomEKgKCNU7aW3nhxYSXxPsw4vPbUX62nd4Eh2VtkKY_Mxx9Hx1-TS_iZf314v5bBk7xlIZO0iUoJSVOhEWXKJT7QynzkA-rKYQ0imhTSkLoUujWJIYBbkxKQWj1FAaR2f7u21o3nrALts0faiHlxnXhgtNE8UHiu8pt938A4xmO6PZr9FsZzTbGR26UnwDwpltig</recordid><startdate>20220323</startdate><enddate>20220323</enddate><creator>Lombardi, J</creator><creator>Almolki, M</creator><creator>Petit, C</creator><creator>Mondoloni, P</creator><creator>Grangeasse, L</creator><creator>Leroy, B</creator><creator>Renzullo, C</creator><creator>Razzouq, N</creator><creator>Penaud, JF</creator><creator>Coutet, J</creator><general>British Medical Journal Publishing Group</general><general>BMJ Publishing Group LTD</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20220323</creationdate><title>5PSQ-027 Misuse assessment and risks of NSAIDs prescriptions for elderly patients in surgical units</title><author>Lombardi, J ; Almolki, M ; Petit, C ; Mondoloni, P ; Grangeasse, L ; Leroy, B ; Renzullo, C ; Razzouq, N ; Penaud, JF ; Coutet, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1194-be853001f683aeb8696b720b7ecaeb7d34b5367f4d36f7518875ec7790e755683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Analgesics</topic><topic>Bone surgery</topic><topic>Conflicts of interest</topic><topic>Diuretics</topic><topic>Patients</topic><topic>Pharmacovigilance</topic><topic>Prescriptions</topic><topic>Section 5: Patient safety and quality assurance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lombardi, J</creatorcontrib><creatorcontrib>Almolki, M</creatorcontrib><creatorcontrib>Petit, C</creatorcontrib><creatorcontrib>Mondoloni, P</creatorcontrib><creatorcontrib>Grangeasse, L</creatorcontrib><creatorcontrib>Leroy, B</creatorcontrib><creatorcontrib>Renzullo, C</creatorcontrib><creatorcontrib>Razzouq, N</creatorcontrib><creatorcontrib>Penaud, JF</creatorcontrib><creatorcontrib>Coutet, J</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>European journal of hospital pharmacy. Science and practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lombardi, J</au><au>Almolki, M</au><au>Petit, C</au><au>Mondoloni, P</au><au>Grangeasse, L</au><au>Leroy, B</au><au>Renzullo, C</au><au>Razzouq, N</au><au>Penaud, JF</au><au>Coutet, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>5PSQ-027 Misuse assessment and risks of NSAIDs prescriptions for elderly patients in surgical units</atitle><jtitle>European journal of hospital pharmacy. Science and practice</jtitle><stitle>Eur J Hosp Pharm</stitle><date>2022-03-23</date><risdate>2022</risdate><volume>29</volume><issue>Suppl 1</issue><spage>A126</spage><epage>A126</epage><pages>A126-A126</pages><issn>2047-9956</issn><eissn>2047-9964</eissn><abstract>Background and importanceNon-steroidal anti-inflammatory drugs (NSAIDs) should be used with caution for elderly patients due to the high risk of gastrointestinal and renal adverse effects (AE). However, this drug class is widely used in the perioperative period for their analgesic properties, to spare using opioids. Due to serious AE imputed by pharmacovigilance in Orthopedic Surgery Departments (OSD), a study of NSAIDs prescriptions was conducted in this care unit. Clinical pharmacy development in OSD highlighted dysfunctions in prescribing NSAIDs for patients aged over 75 years who are at high risk of AE.Aim and objectivesTo quantify how commonly postoperative prescription of NSAIDs are used and to assess the risks associated for patients aged over 75 years in OSD.Material and methodsWe performed a retrospective, observational study between January and October 2021 on all NSAIDs prescriptions for patients aged over 75 years in OSD. Treatments which may cause renal failure in elderly patients (angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin receptor blockers (ARB), diuretics) were noted. Specific attention was given to patients having presented a serious AE including a declaration to pharmacovigilance.ResultsIn total, 584 patients received NSAIDs in the OSD. 80 patients were aged over 75 years (13.7%), of which 21 patients were taking ACE inhibitors (26%) at the same time, 17 patients an ARB (21%) and 13 patients diuretics (16%). A combination of three nephrotoxic drugs was found for 2 patients and a combination of two for 20 patients. The median creatinine before surgery was 69 µM (40–141 µM) and median renal clearance was 78 mL/min. Serious renal AE were identified in 5 patients (6.25%) leading to prolonged hospitalisation and haemodialysis for one patient. AE were present within 48 hours of taking NSAIDs. No other AE were detected.Conclusion and relevanceThe inappropriate prescriptions of NSAIDs observed in elderly patient and their association with other potentially nephrotoxic drugs increases the risk of renal AE. The actions implemented initially were setting analgesic protocols adapted to the patient’s age according to the latest recommendations. Secondly, both pharmaceutical and medical prescriptions were being monitored daily. Since surgery involves several prescribers (anaesthesiologists, surgeons, doctors), harmonising prescription practices is currently being considered.References and/or acknowledgementsConflict of interestNo conflict of interest</abstract><cop>London</cop><pub>British Medical Journal Publishing Group</pub><doi>10.1136/ejhpharm-2022-eahp.264</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2047-9956
ispartof European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A126-A126
issn 2047-9956
2047-9964
language eng
recordid cdi_proquest_journals_2672360852
source PubMed (Medline); EZB Electronic Journals Library
subjects Analgesics
Bone surgery
Conflicts of interest
Diuretics
Patients
Pharmacovigilance
Prescriptions
Section 5: Patient safety and quality assurance
title 5PSQ-027 Misuse assessment and risks of NSAIDs prescriptions for elderly patients in surgical units
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T18%3A51%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_bmj_j&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=5PSQ-027%E2%80%85Misuse%20assessment%20and%20risks%20of%20NSAIDs%20prescriptions%20for%20elderly%20patients%20in%20surgical%20units&rft.jtitle=European%20journal%20of%20hospital%20pharmacy.%20Science%20and%20practice&rft.au=Lombardi,%20J&rft.date=2022-03-23&rft.volume=29&rft.issue=Suppl%201&rft.spage=A126&rft.epage=A126&rft.pages=A126-A126&rft.issn=2047-9956&rft.eissn=2047-9964&rft_id=info:doi/10.1136/ejhpharm-2022-eahp.264&rft_dat=%3Cproquest_bmj_j%3E2672360852%3C/proquest_bmj_j%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2672360852&rft_id=info:pmid/&rfr_iscdi=true